Prognostic significance of longitudinal strain in dilated cardiomyopathy with recovered ejection fraction

Marco Merlo1, Marco Masè1, Andrew Perry2

  • 1Cardiology Unit, Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy.

Insights

In patients with non-ischaemic dilated cardiomyopathy (NICM) who recover normal left ventricular ejection fraction (LVEF), impaired global longitudinal strain (aGLS) is common. This reduced aGLS is linked to a higher risk of mortality during follow-up.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Heart Failure Research

Background:

  • Non-ischaemic dilated cardiomyopathy (NICM) can present with normalized left ventricular ejection fraction (LVEF) during recovery.
  • Despite LVEF normalization, patients with NICM still face an elevated risk of mortality.
  • Current risk stratification tools for NICM patients with recovered LVEF are lacking.

Purpose of the Study:

  • To investigate the association between absolute global longitudinal strain (aGLS) and all-cause mortality in NICM patients with recovered LVEF.
  • To determine if aGLS can serve as a prognostic marker in this specific patient population.

Main Methods:

  • Retrospective, international, longitudinal cohort study.
  • Inclusion of NICM patients with initial LVEF <40% and subsequent recovery to LVEF >50%.
  • Measurement of aGLS at the time of LVEF normalization and correlation with all-cause mortality during follow-up.

Main Results:

  • 206 patients were included; median follow-up was 5.5 years, with 17% mortality.
  • Impaired aGLS (≤18%) was frequent (80%), with 68% having aGLS <16%.
  • aGLS at LVEF recovery was independently associated with mortality (adjusted HR 0.90; p=0.048). No deaths occurred with normal aGLS (>18%).

Conclusions:

  • Impaired aGLS is common in NICM patients with normalized LVEF.
  • Reduced aGLS at the time of LVEF recovery is associated with worse long-term outcomes and increased mortality risk.
  • aGLS may provide valuable prognostic information for risk-stratifying NICM patients with recovered LVEF.
Abstract